Data from: Post-marketing surveillance of the safety and effectiveness of metreleptin in patients with lipodystrophy in Japan

Description

Supplementary appendix for Title: Post-marketing surveillance of the safety and effectiveness of metreleptin in patients with lipodystrophy in Japan Ken Ebihara 1, Tomohisa Hata 2, Yumi Sato 3, and Makiko Miyano4 Affiliations: 1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan 2. Pharmacovigilance Department, Shionogi & Co., Ltd., Osaka, Japan 3. Medical Affairs Department, Shionogi & Co., Ltd., Osaka, Japan 4. Pharmacovigilance Division, Shionogi Business Partner Co., Ltd., Osaka, Japan Correspondence to: Name: Ken Ebihara

Categories

Licence